Cargando…
First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection
Autores principales: | Perrot, Lea, Hemon, Marie, Busnel, Jean-Marc, Muis-Pistor, Olivier, Picard, Christophe, Zandotti, Christine, Pham, Thao, Roudier, Jean, Desplat-Jego, Sophie, Balandraud, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832430/ https://www.ncbi.nlm.nih.gov/pubmed/33521668 http://dx.doi.org/10.1016/S2665-9913(20)30396-9 |
Ejemplares similares
-
HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis
por: Balandraud, Nathalie, et al.
Publicado: (2013) -
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study
por: Balandraud, Nathalie, et al.
Publicado: (2017) -
In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope
por: Larid, Guillaume, et al.
Publicado: (2021) -
Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research
por: Cartagena García, Celia, et al.
Publicado: (2022) -
Peptidylarginine Deiminase Autoimmunity and the Development of Anti–Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten–Carrier Model
por: Auger, Isabelle, et al.
Publicado: (2020)